Text Messaging Reminders for Influenza Vaccine in Primary Care
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
The Benefit and Harm of Fever Suppression by Antipyretics in Influenza
- Status
- COMPLETED
- Phase
- PHASE4
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
- Status
- COMPLETED
- Phase
- PHASE4
Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza
- Status
- COMPLETED
- Phase
- PHASE4
Safety of H1N1 Influenza Vaccination in Pregnant Women
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients
- Status
- COMPLETED
- Phase
- N/A
Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)
- Status
- COMPLETED
- Phase
- PHASE4
Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women
- Status
- COMPLETED
- Phase
- PHASE4
High-Dose Influenza Vaccine in Nursing Homes
- Status
- UNKNOWN
- Phase
- PHASE4
Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women
- Status
- COMPLETED
- Phase
- PHASE4
Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza
- Status
- COMPLETED
- Phase
- PHASE4